Vitamin D and androgen regulation of prostatic growth

Journal of Cellular Biochemistry

Volumn 90, Issue 1, 2003, Pages 138-147

  Leman, Eddy S ^a   Arlotti, Julie A ^a   Dhir, Rajiv ^a,b   Getzenberg, Robert H ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

AR; Normal prostate; Testosterone; VDR; Vitamin D

Indexed keywords

ANDROGEN RECEPTOR; CALCITRIOL; TESTOSTERONE; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEVELOPMENTAL BIOLOGY; DEVELOPMENTAL STAGE; GROWTH INHIBITION; IMMUNOBLOTTING; INHIBITION KINETICS; MALE; NONHUMAN; ORGAN SIZE; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE; PROTEIN CONTENT; RAT; REGULATORY MECHANISM;

ANIMALS; CALCITRIOL; CASTRATION; MALE; ORGAN SIZE; PROSTATE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANDROGEN; RECEPTORS, CALCITRIOL; TESTOSTERONE;

ANIMALIA;

EID: 0042320946     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10605     Document Type: Article

References (18)

1. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. 2000. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11:847-852.
2. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. 1995. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 6:235-239.
3. Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N. 1993. Vitamin D and prostate cancer: A prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2:467-472.
4. Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ. 1996. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 5:121-126.
5. Hanchette CL, Schwartz GG. 1992. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70:2861-2869.
6. Hsieh T, Wu JM. 1997. Induction of apoptosis and altered nuclear/cytoplasmic distribution of the androgen receptor and prostate-specific antigen by 1alpha,25-dihydroxyvitamin D3 in androgen-responsive LNCaP cells. Biochem Biophys Res Commun 235:539-544.
7. Hsieh TY, Ng CY, Mallouh C, Tazaki H, Wu JM. 1996. Regulation of growth, PSA/PAP, and androgen receptor expression by 1 alpha,25-dihydroxyvitamin D3 in the androgen-dependent LNCaP cells. Biochem Biophys Res Commun 223:141-146.
8. Konety BR, Schwartz GG, Acierno JS, Jr., Becich MJ, Getzenberg RH. 1996. The role of vitamin D in normal prostate growth and differentiation. Cell Growth Differ 7:1563-1570.
9. Konety BR, Nangia AK, Nguyen TS, Thomas A, Getzenberg RH. 1999. Effect of prenatal vitamin D (calcitriol) exposure on the growth and development of the prostate. Prostate 41:181-189.
10. Konety BR, Leman E, Vietmeier B, Arlotti J, Dhir R, Getzenberg RH. 2000. In vitro and in vivo effects of vitamin D (calcitriol) administration on the normal neonatal and prepubertal prostate. J Urol 164:1812-1818.
11. Makela S, Santti R, Martikainen P, Nienstedt W, Paranko J. 1990. The influence of steroidal and nonsteroidal estrogens on the 5 alpha-reduction of testosterone by the ventral prostate of the rat. J Steroid Biochem 35:249-256.
12. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D. 1994. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54:805-810.
13. Schulze H, Claus S. 1990. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. Prostate 16:331-343.
14. Schwartz GG, Hulka BS. 1990. Is vitamin D deficiency a risk factor for prostate cancer? (hypothesis). Anticancer Res 10:1307-1311.
15. Tuohimaa P, Lyakhovich A, Aksenov N, Pennanen P, Syvala H, Lou YR, Ahonen M, Hasan T, Pasanen P, Blauer M, Manninen T, Miettinen S, Vilja P, Ylikomi T. 2001. Vitamin D and prostate cancer. J Steroid Biochem Mol Biol 76:125-134.
16. Wernert N, Gerdes J, Loy V, Seitz G, Scherr O, Dhom G. 1988. Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis. Virchows Arch A Pathol Anat Histopathol 412:387-391.
17. Zhao XY, Ly LH, Peehl DM, Feldman D. 1997. 1-alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent. Endocrinology 138:3290-3298.
18. Zhao XY, Ly LH, Peehl DM, Feldman D. 1999. Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells. Endocrinology 140:1205-1212.